| Revenue growth | Consolidated revenue +17.3% YoY; H1 +17.4% |
|---|---|
| Margins | Q2 PAT margin 11.6% vs 13.1%; hospital EBITDA 23.3% |
| Demand visibility | Renal, Neuro, Ortho revenue up 27%, 28%, 30% |
Growth
Revenue +17.3% to INR 2,735 Cr; PBT +6.8% to 429 Cr; PAT +4.0% to 317 Cr. Hospital revenue +18.6%; diagnostics +12.2%.
Outlook
Targets ~12,000 beds in 3-5 years. Acquired Suguna (INR 277 Cr cash); 400+ bed Delhi hospital opens in 3-4 years.
Risks
PAT lagged revenue; margin 11.6% vs 13.1%. Hospital PAT margin down to 12.0% from 13.4%; ESOP cost INR 39 Cr.
Investor Presentation filed with NSE, NSE: FORTIS. Summary written with AI assistance from the document.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹819.80
- Market cap
- ₹61,891 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 59.1×Sector 54.5×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 23.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Results Update
Fortis Healthcare released a press release on Q2 FY27 results, with consolidated revenue of INR 2,735 Cr up 17.3%. It also disclosed the Suguna Hospital acquisition and a 400+ bed Delhi hospital services agreement.
- hospital beds acquired
- 110.0 beds
Fortis Healthcare Q2 FY27 Results: Net Profit ₹320.5 Cr, Down 2.5% YoY
Fortis Healthcare approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026 at its board meeting on November 5, 2026. The filing encloses the results and a limited review report with an emphasis on a SFIO fraud investigation.
- Key figure
- Net profit ₹320.5 Cr · -2.5% YoY
Fortis Healthcare Management Change
Fortis Healthcare's Chief Growth & Innovation Officer, Dr. Ritu Garg, resigned effective close of business on October 31, 2026. The resignation is a senior management personnel change with no monetary impact stated.
Fortis Healthcare Board Meeting Date
Fortis Healthcare will hold a board meeting on 5 November 2026 to approve Q2 and half-year unaudited results and alter terms of ₹1,550 Crore listed NCDs. The filing is a prior intimation of the board meeting with agenda items only.
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr
Fortis Healthcare Acquisition Worth ₹277 Cr
Fortis Healthcare's wholly-owned subsidiary IHL acquired Suguna Hospital's business and land in Bengaluru via slump sale. The cumulative consideration is approximately INR 277 Crore, consummated today.
- Value
- ₹277.0 Cr